Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine. Drugs and Therapy Studies, [S. l.], v. 2, n. 1, p. e1, 2011. DOI: 10.4081/dts.2012.e1. Disponível em: https://journals.pagepress.net/dts/article/view/dts.2012.e1. Acesso em: 22 sep. 2026.